New perspectives on folate status: A differential role for the vitamin in cardiovascular disease, birth defects and other conditions

British Journal of Biomedical Science

Volumn 57, Issue 3, 2000, Pages 254-260

  Lucock, M ^a   Daskalakis, I ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Folic acid; Heart diseases; Homocysteine; Neoplasms; Neural tube defects; One carbon metabolism

Indexed keywords

ALANINE; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; DIHYDROFOLATE REDUCTASE; FOLIC ACID; HOMOCYSTEINE; METHIONINE; METHIONINE SYNTHASE; OXIDOREDUCTASE; POLYGLUTAMIC ACID; PURINE; PYRIMIDINE; S ADENOSYLMETHIONINE; SERINE; TETRAHYDROFOLIC ACID; THYMIDYLATE SYNTHASE; TRANSFERASE; VALINE; VITAMIN B GROUP;

ADULT; AFFECTIVE NEUROSIS; ALZHEIMER DISEASE; AMINO ACID SYNTHESIS; ARTICLE; BIOSYNTHESIS; BIRTH DEFECT; CANCER; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; COENZYME; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; FOLATE METABOLISM; HUMAN; HUMAN CELL; INFANT; NEURAL TUBE DEFECT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PURINE SYNTHESIS; PYRIMIDINE SYNTHESIS; SPINA BIFIDA;

CARDIOVASCULAR DISEASES; FOLIC ACID; HOMOCYSTEINE; HUMAN; INFANT, NEWBORN; NEURAL TUBE DEFECTS; SUPPORT, NON-U.S. GOV'T;

EID: 0033806352     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Folate and the prevention of disease
2. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
3. Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects and folic acid
4. Folate status, women's health, pregnancy outcome and cancer
5. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer
6. 12 on squamous metaplasia of the bronchial epithelium
7. Enhancement of recovery from psychiatric illness by methylfolate
8. 12 and serum total homocysteine levels in confirmed Alzheimer's disease
9. Serum folates in man
10. Non-enzymatic degradation and salvage of dietary folate: Physicochemical factors likely to influence bioavailability
11. A rapid and specific HPLC-electrochemical method for the determination of endogenous 5-methyltetrahydrofolic acid in plasma using solid phase sample preparation with internal standardisation
12. Folypolyglutamates as substrates and inhibitors of folate dependent enzymes
13. Impaired regeneration of monoglutamyl tetrahydrofolate leads to cellular folate depletion in mothers affected by a spina bifida pregnancy
14. Folate-homocysteine interrelations: Potential new markers of folate status
15. Prospective studies of homocysteine and cardiovascular disease
16. Relation of serum homocysteine and lipoprotein (A) concentrations to atherosclerotic disease in a prospective Finnish population-based study
17. Prospective study of serum total homocysteine concentrations and risk of stroke in middle-aged British men
18. Plasma homocysteine as a risk factor for atherothrombotic events in systematic lupus erythematosus
19. Carotid artery intimal-medial thickening and plasma homocysteine in asymptomatic adults: The atherosclerosis risk in communities study
20. Association between plasma homocysteine concentration and extracranial carotid-artery stenosis
21. Homocysteine and hypomethylation, a novel link to vascular disease
22. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
23. The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and trans-sulphuration of homocysteine
24. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
25. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocysteinuria
26. 12 are independent risk factors for neural tube defects
27. 12) increases risk for spina bifida
28. 5, 10-methylenetetrahydrofolate reductase C677T genotypes and folate-related risk factors for neural tube defects
29. The responsiveness of plasma homocysteine to small increases in dietary folic acid: A primary care study
30. Homocysteine and neural tube defects
31. Methionine synthase and neural tube defects
32. Common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells
33. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects
34. The structure and properties of methylenetetrahydrofolate reductase from E. coli suggest how folate ameliorates human hyperhomocysteinaemia
35. Transcriptional repression by methylation cooperativity between a CpG cluster in the promoter and remote CpG-rich regions
36. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic-acid depletion in human lymphocytes in vitro
37. A prospective study of folate intake and the risk of breast cancer
38. 12, and pyridoxal 5'-phosphate (B6) and breast cancer
39. Familial clustering of neural tube defects and gastric cancer
40. Treatment of pernicious anaemia of pregnancy and tropical anaemia, with special reference to yeast extract as curative agent
41. The megaloblastic anaemias
42. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism
43. In vivo characterisation of the absorption and biotransformation of pteroylglutamic acid in man: A model for future studies
44. Unmetabolised folic acid in serum: Acute studies in subjects consuming fortified food and supplements